You can buy or sell Coloplast and other stocks, options, ETFs, and crypto commission-free!
Coloplast A/S develops, manufactures, and markets medical products. It operates through the following segments: Chronic Care; Urology Care; and Wound and Skin Care. Read More The Chronic Care segment covers the sale of ostomy care products and continence care products. The Urology Care segment covers the sale of urological products, including disposable products. The Wound and Skin Care segment covers the sale of wound and skin care products. The company was founded by Aage Louis-Hansen and Johanne Louise-Hansen in 1957 and is headquartered in Humlebaek, Denmark. CLPBY is listed on the Pink Current market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com).
52 Week High
52 Week Low
Yahoo FinanceMay 13
Coloplast share buy-back week 19/2019
Announcement 13 May 2019 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 2/2019 Coloplast has initiated the second part of the share buy-back programme totalling up to DKK 1bn. This part of the programme of DKK500m is expected to take place from 25 February, 2019 to 23 August, 2019. The buy-back programme will be structured in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Regula...
BAX vs. CLPBY: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Products sector have probably already heard of Baxter International (BAX) and Coloplast A/S (CLPBY). But which of these two stocks is more attractive to value investors?
Yahoo FinanceMay 7